132 related articles for article (PubMed ID: 9376926)
1. [Intravenous corticosteroid megadose treatment in ocular Behçet disease].
Postelmans L; Verougstraete C; Libert J; Efira A; Caspers-Velu L
Bull Soc Belge Ophtalmol; 1996; 262():95-103. PubMed ID: 9376926
[TBL] [Abstract][Full Text] [Related]
2. Fluorescein angiography and visual acuity in active uveitis with Behçet disease.
Yu HG; Kim MJ; Oh FS
Ocul Immunol Inflamm; 2009; 17(1):41-6. PubMed ID: 19294573
[TBL] [Abstract][Full Text] [Related]
3. A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet's disease: a comparative 4-week study.
Markomichelakis N; Delicha E; Masselos S; Fragiadaki K; Kaklamanis P; Sfikakis PP
Rheumatology (Oxford); 2011 Mar; 50(3):593-7. PubMed ID: 21097877
[TBL] [Abstract][Full Text] [Related]
4. Macular ischaemia in Behçet's disease.
Yilmaz G; Akova Y; Aydin P
Eye (Lond); 2000 Oct; 14 Pt 5():717-20. PubMed ID: 11116691
[TBL] [Abstract][Full Text] [Related]
5. [Ocular prognosis in Behçet's disease].
Cochereau-Massin I; Wechsler B; Le Hoang P; Le Thi Huong Du; Girard B; Rousselie F; Godeau P
J Fr Ophtalmol; 1992; 15(5):343-7. PubMed ID: 1430813
[TBL] [Abstract][Full Text] [Related]
6. Panuveitis associated with multiple sclerosis complicated by cerebral venous thrombosis.
Kadayifçilar S; Gedik S; Eldem B; Balaban H; Kansu T
Ocul Immunol Inflamm; 2004 Jun; 12(2):153-7. PubMed ID: 15512986
[TBL] [Abstract][Full Text] [Related]
7. Retinal tears associated with panuveitis and Behçet's disease.
Akova YA; Yilmaz G; Aydin P
Ophthalmic Surg Lasers; 1999; 30(9):762-5. PubMed ID: 10574500
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
[TBL] [Abstract][Full Text] [Related]
9. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Tabbara KF; Al-Hemidan AI
Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
[TBL] [Abstract][Full Text] [Related]
10. Vitrectomy for persistent panuveitis in Behçet's disease.
Ahn JK; Chung H; Yu HG
Ocul Immunol Inflamm; 2005 Dec; 13(6):447-53. PubMed ID: 16321889
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine in Behçet's disease resistant to conventional therapy.
Caspers-Velu LE; Decaux G; Libert J
Ann Ophthalmol; 1989 Mar; 21(3):111-6, 118. PubMed ID: 2735696
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
[TBL] [Abstract][Full Text] [Related]
13. Uveitis in Behçet disease: an analysis of 880 patients.
Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
[TBL] [Abstract][Full Text] [Related]
14. Pars plana vitrectomy for ocular complications of Behçet's disease.
Sullu Y; Alotaiby H; Beden U; Erkan D
Ophthalmic Surg Lasers Imaging; 2005; 36(4):292-7. PubMed ID: 16156145
[TBL] [Abstract][Full Text] [Related]
15. Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.
Keino H; Okada AA; Watanabe T; Taki W
Br J Ophthalmol; 2011 Sep; 95(9):1245-50. PubMed ID: 21183514
[TBL] [Abstract][Full Text] [Related]
16. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
17. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
18. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
19. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
20. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
